Arrivent BioPharma, Inc. (AVBP)

22.09 -0.20 (-0.90%) USD  |  NASDAQ  |  Dec 26, 10:57
More

Arrivent BioPharma EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for AVBP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
CEL-SCI Corp. Upgrade
IGC Pharma, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade